Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males

Pere N. Roset, Magı́ Farré, Rafael de la Torre, Marta Mas, Esther Menoyo, Celia Hernández, Jordi Camı́

Research output: Contribution to journalArticleResearchpeer-review

37 Citations (Scopus)

Abstract

Low, medium, and high doses of flunitrazepam were tested in three independent randomized, double-blind, balanced cross-over, placebo-controlled trials to study the influence of rate of onset of effects and dose administered on its acute effects. Three groups of 12 healthy male volunteers received six oral doses of placebo or flunitrazepam in slow and fast onset conditions as follows: six capsules of 0.16 mg (slow) and a single capsule of 0.8 mg (fast) in the low dose trial; six 0.25 mg (slow) and a single 1.25 mg (fast) capsules for medium dose; and six 0.4 mg (slow) and a single 2 mg (fast) capsule for high dose. At each dose level, slow or fast increasing flunitrazepam plasma concentrations lead to similar peak levels, but induced differential subjective and behavioral effects. In addition to objective and subjective sedation, flunitrazepam induced some pleasurable feelings, which were more intense in the fast than in the slow conditions. At the highest dose, unpleasant sedative effects surmounted positive effects, while at the lowest dose pleasurable effects were of low intensity. At the medium dose, the balance between pleasurable and unpleasant feelings resulted in euphorigenic effects, which were evident in the fast condition but were blunted in the slow condition. © 2001 Elsevier Science Ireland Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)285-298
JournalDrug and Alcohol Dependence
Volume64
Issue number3
DOIs
Publication statusPublished - 1 Nov 2001

Keywords

  • Absorption rate
  • Abuse liability
  • Flunitrazepam
  • Pharmacokinetics
  • Rate of onset of effects

Fingerprint Dive into the research topics of 'Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males'. Together they form a unique fingerprint.

Cite this